EP 1819690 A2 20070822 - CHROMAN COMPOUNDS
Title (en)
CHROMAN COMPOUNDS
Title (de)
CHROMANVERBINDUNGEN
Title (fr)
COMPOSES DE TYPE CHROMANE
Publication
Application
Priority
- IB 2005003485 W 20051115
- GB 0426061 A 20041126
Abstract (en)
[origin: WO2006056850A2] PC26133A The present invention provides for compounds of formula (I) wherein A, R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4</SUP> and R<SUP>5</SUP> are defined herein. The compounds of formula (I) are a class of dopamine agonists, more particularly a class of agonists that are selective for D3 over D2. These compounds are useful for the treatment and/or prevention of neuropsychiatric disorders, neurodegenerative disorders, pain and sexual dysfunction.
IPC 8 full level
C07D 311/58 (2006.01); C07D 405/04 (2006.01); C07D 413/04 (2006.01); C07D 491/04 (2006.01); C07D 493/04 (2006.01)
CPC (source: EP)
A61P 15/00 (2017.12); A61P 15/10 (2017.12); A61P 25/00 (2017.12); A61P 25/02 (2017.12); A61P 25/04 (2017.12); A61P 25/18 (2017.12); A61P 25/24 (2017.12); A61P 43/00 (2017.12); C07D 311/58 (2013.01); C07D 405/04 (2013.01); C07D 413/04 (2013.01); C07D 491/04 (2013.01); C07D 493/04 (2013.01)
Citation (search report)
See references of WO 2006056850A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2006056850 A2 20060601; WO 2006056850 A3 20060824; CA 2587860 A1 20060601; EP 1819690 A2 20070822; GB 0426061 D0 20041229; JP 2008521789 A 20080626
DOCDB simple family (application)
IB 2005003485 W 20051115; CA 2587860 A 20051115; EP 05806475 A 20051115; GB 0426061 A 20041126; JP 2007542156 A 20051115